|
Profile Visibility  | | #2,450 in weekly profile views out of 12,337 lawyers in Boston, Massachusetts | | #190,627 in weekly profile views out of 968,464 total lawyers Overall |
|
|
| |
| Practice Areas | Intellectual Property Litigation; Major Commercial Litigation; Life Sciences; Antitrust and Trade Regulation; Class Actions; Litigation | | | Education | University of Pennsylvania, J.D., 1992, Tufts University, B.A., 1988 | | | Admitted | 1992, Massachusetts; U.S. Court of Appeals, Federal Circuit; U.S. District Court, District of Massachusetts; U.S. Supreme Court | |
| Memberships | Boston, Massachusetts and American (Member, Sections on: Intellectual Property; Litigation) Bar Associations; American Intellectual Property Law Association. | | | Born | 1966 | | | Biography | Intellectual Property Litigation: patent infringement, licensing disputes and other intellectual property litigation on behalf of major pharmaceutical and biotech companies and clients in the high tech industry. Complex Commercial Litigation: securities and antitrust litigation, state and federal investigations of Medicare and Medicaid Fraud, anti-kickback and drug record keeping violations. Intellectual Property Counseling and Due Diligence: assessment of intellectual property matters, Orange book issues and regulatory matters in connection with collaborations, acquisitions and joint ventures, particularly in the life sciences industries. | | | ISLN | 900909168 | | | Transactions | Lead Counsel for Wyeth in ANDA patent action brought against Teva relating to prescription sleep aid marketed by King. King Pharmaceuticals and Wyeth v. Teva, Dist. N.J. Lead Counsel for Wyeth in breach of contract dispute relating to Celera's genomics database products. Applera Corp., d/b/a Celera Genomics Group v. Wyeth, Montgomery County, Md. Cir. Ct. Lead Counsel to Natures Remedies and Zoller in patent infringement action involving herbal composition for weight loss. Natures Remedies Ltd. and Zoller Laboratories v. NBTY, Inc., Dist. Utah. Lead Counsel for Sapidyne in patent infringement action involving antibody-based detection tool. Sapidyne Instruments, Inc. v. Biomatrix Solutions, LLC, et al., Dist. Idaho. Eisai, Inc. and Eisai Research Institute of Boston, Inc (collectively "Eisai"), one of eleven major pharmaceutical companies sued for infringement of four patents to certain cell-based screening assays. Housey Pharmaceuticals, Inc. v. Abbott Pharmaceutical Corp., et al., Dist. Del. Counsel for Eisai Co., Ltd. One of two partners representing GSI in patent infringement action involving laser marking technology. GSI Lumonics Corp v. A-B Lasers, Inc., Eastern Dist. Mich.; Judgment on appeal reversing $34 million verdict against Powerscreen. The Read Corporation, et al. v. Powerscreen International, PLC, et al. ("Powerscreen"), U.S. Dist. Ct. for Dist. Mass. One of three partners representing Genetics Institute in contract dispute relating to manufacture of recombinant Factor VIII for treatment of hemophilia. A. Baxter HealthCare, Inc. v. Genetics Institute, Inc., Del. Chancery Court. Counsel for Genetics Institute in patent infringement and breach of contract litigation relating to Genetic Institute's development of recombinant Factor VIII. Genetics Institute, et al. v. Baxter International, Inc., et al., D. Mass. Along with Co-Counsel, represented defendants TKT and HMR in patent infringement litigation brought by Amgen to prevent TKT from commercializing its patented gene-activated erythropoeitin product. Amgen, Inc. v. Hoechst Marion Roussel, Inc. and Transkaryotic Therapies, Inc., D. Mass.; Along with co-counsel, represented Berlex Laboratories in patent infringement litigation involving recombinant beta interferon for treatment of multiple sclerosis. Biogen v. Berlex Laboratories, D. Mass. Counsel for Tallon and its licensee American Superconductor, Inc. in patent interference proceedings involving class of high temperature superconducting ceramic oxides. Tallon, et al. v. Maeda, et al. and others, U.S. Patent & Trademark Office, Board of Patent Appeals and Interferences. | |
|
|
RSS | Blog | Advertising Opportunities | Site Map | Contact Us
